 | |
 | |
| Clinical data | |
|---|---|
| Other names | 2C-G-0; 2,5-Dimethoxy-3,4-dimethylphenethylamine; 3,4-Dimethyl-2,5-dimethoxyphenethylamine; 3-Methyl-2C-D |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 18–30 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO2 |
| Molar mass | 209.289 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
2C-G, or2C-G-0, also known as3,4-dimethyl-2,5-dimethoxyphenethylamine or as3-methyl-2C-D, is apsychedelicphenethylamine of the2C family.[1] Firstsynthesized byAlexander Shulgin, it has structural and pharmacodynamic properties similar to2C-D andGanesha (G).[1] The drug has a number of knownhomologues, which are known as the 2C-G series of compounds.[1]
InAlexander Shulgin's bookPiHKAL (Phenethylamines I Have Known and Loved), the dose range is listed as 20 to 35 mgorally.[1] Effects are similar to the relatedGanesha, and are extremely long lasting; theduration is 18 to 30 hours.[1]Visual effects are muted or absent, and it is described as an "insight-enhancer".[1] Unlike other members of the2C series, 2C-G is nearly as potent as itsamphetamine form.[1]
Thechemical synthesis of 2C-G has been described.[1]
Severalhomologues of 2C-G were also synthesized byAlexander Shulgin.[1] These include2C-G-3,2C-G-5, and2C-G-N.[1] Some, such as 2C-G-1, 2C-G-2,2C-G-4, and 2C-G-6, are possible to synthesize in principle but impossible or extraordinarily difficult to do so in practice.[1]
| Compound | Details | Structure |
|---|---|---|
| 2C-G-1 | CAS: 2888537-47-9 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 |  |
| 2C-G-2 | CAS: 2888537-48-0 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 |  |
| 2C-G-3 | CAS: 207740-19-0 Dose: 16–25 mg |  |
| 2C-G-4 | CAS: 952006-59-6 Partially synthesized but not tested. |  |
| 2C-G-5 | CAS: 207740-20-3 Dose: 10–16 mg |  |
| 2C-G-6 | CAS: 2888537-49-1 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 |  |
| 2C-G-N | CAS: 207740-21-4 Dose: 20–40 mg |  |
2C-G was first described in the literature byAlexander Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]
As of October 31, 2016; 2C-G is a controlled substance (Schedule III) in Canada.[2]
2C-G and all other compounds featuring inPiHKAL areClass A drugs in theUnited Kingdom.
In the United States 2C-G is considered a Schedule Icontrolled substance as apositional isomer of2C-E andDOM.[3]
